These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20131275)

  • 1. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models.
    Hoek RM; de Launay D; Kop EN; Yilmaz-Elis AS; Lin F; Reedquist KA; Verbeek JS; Medof ME; Tak PP; Hamann J
    Arthritis Rheum; 2010 Apr; 62(4):1036-42. PubMed ID: 20131275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD97 neutralisation increases resistance to collagen-induced arthritis in mice.
    Kop EN; Adriaansen J; Smeets TJ; Vervoordeldonk MJ; van Lier RA; Hamann J; Tak PP
    Arthritis Res Ther; 2006; 8(5):R155. PubMed ID: 17007638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2.
    de Groot DM; Vogel G; Dulos J; Teeuwen L; Stebbins K; Hamann J; Owens BM; van Eenennaam H; Bos E; Boots AM
    J Immunol; 2009 Sep; 183(6):4127-34. PubMed ID: 19717518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.
    Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP
    Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55.
    Karpus ON; Veninga H; Hoek RM; Flierman D; van Buul JD; Vandenakker CC; vanBavel E; Medof ME; van Lier RA; Reedquist KA; Hamann J
    J Immunol; 2013 Apr; 190(7):3740-8. PubMed ID: 23447688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis.
    Suchard SJ; Stetsko DK; Davis PM; Skala S; Potin D; Launay M; Dhar TG; Barrish JC; Susulic V; Shuster DJ; McIntyre KW; McKinnon M; Salter-Cid L
    J Immunol; 2010 Apr; 184(7):3917-26. PubMed ID: 20190141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
    Lange F; Bajtner E; Rintisch C; Nandakumar KS; Sack U; Holmdahl R
    Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).
    Hückel M; Schurigt U; Wagner AH; Stöckigt R; Petrow PK; Thoss K; Gajda M; Henzgen S; Hecker M; Bräuer R
    Arthritis Res Ther; 2006; 8(1):R17. PubMed ID: 16507120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis.
    Han Z; Chang L; Yamanishi Y; Karin M; Firestein GS
    Arthritis Rheum; 2002 Mar; 46(3):818-23. PubMed ID: 11920420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
    Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
    Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of arthritis severity in protease-activated receptor-deficient mice.
    Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
    Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis.
    Okumura A; Saito T; Otani I; Kojima K; Yamada Y; Ishida-Okawara A; Nakazato K; Asano M; Kanayama K; Iwakura Y; Suzuki K; Yamagoe S
    Arthritis Rheum; 2008 Feb; 58(2):413-21. PubMed ID: 18240267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
    Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
    Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
    J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new quantitative trait loci in mice with collagen-induced arthritis.
    Bauer K; Yu X; Wernhoff P; Koczan D; Thiesen HJ; Ibrahim SM
    Arthritis Rheum; 2004 Nov; 50(11):3721-8. PubMed ID: 15529344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.